Launch of crowdfunding for diabetes devices that scan the human eye
MedTech Occuity today launched a crowdfunding campaign develop devices to detect the first signs of chronic disease by scanning the human eye.
Founded in 2019, Occuity has developed and patented non-contact optical technology to obtain precise measurements of the eye.
She is seeking an investment of £ 1.8million through Seedrs to commercialize a range of new medical devices using this technology for eye exams, diabetes management, prediabetes screening and, longer term, early detection of Alzheimer’s disease.
Efforts to bring these new devices to market are led by Occuity Founder and CEO Dr Dan Daly, Company Co-Founder and CTO Dr Robin Taylor, and Daniele De Iuliis, a 27-year veteran of Apple’s industrial design team, who joined Occuity as a designer. director in 2020.
Occuity’s first device is intended for the optometry market and measures corneal thickness with micrometric precision. This is expected to begin clinical testing and is expected to be approved for use in the EU by early 2022.
The company plans to launch a prediabetes screening device in 2024 to enable mass testing for emerging signs of type 2 diabetes in pharmacies and opticians.
In 2025, he plans to introduce a non-invasive personal optical glucometer that will allow people with diabetes to monitor their blood sugar levels without drawing blood.
Investors support magic mushroom drug MedTech
Occuity hopes that its research and development will also support the delivery of a routine screening device capable of detecting the first signs of Alzheimer’s disease by identifying biomarkers deposited in the eye.
“The eye offers a window on human health. Occuity’s vision is to use this window to identify chronic conditions faster and earlier with non-invasive, contactless wearable devices, and to provide tools to better manage these conditions, ”said Dr. Dan Daly.
“There is a huge opportunity to make a dramatic change over the next decade in the practice of optometry and the way chronic diseases like diabetes and Alzheimer’s disease are detected and managed.
“We invite those who share our vision of transforming medical screening to invest in our crowdfunding campaign to improve the lives of hundreds of millions of people around the world.”
Listed MedTech Creo to Raise £ 35million for Expansion
De Iuliis added, “Thanks to Occuity’s ingenuity, it becomes possible to detect and manage debilitating health problems with a fast, non-contact eye scanner.
“We are developing revolutionary medical devices for use in non-clinical and patient environments. They will be nicer, more intuitive and more practical than existing technologies, and they will be accessible to everyone.